These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16463221)

  • 1. [Functional imaging in movement disorders].
    Swiat M; Opala G; Jasińska-Myga B
    Neurol Neurochir Pol; 2006; 40(1):42-50. PubMed ID: 16463221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.
    Gerasimou GP; Aggelopoulou TC; Costa DC; Gotzamani-Psarrakou A
    Nucl Med Rev Cent East Eur; 2006; 9(2):147-53. PubMed ID: 17304479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty.
    Felicio AC; Shih MC; Godeiro-Junior C; Andrade LA; Bressan RA; Ferraz HB
    Neurologist; 2009 Jan; 15(1):6-16. PubMed ID: 19131852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
    Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
    Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is functional imaging useful in the clinical evaluation of Parkinson's disease?].
    Remy P
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S57-61. PubMed ID: 12773889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of imaging in the diagnosis of vascular parkinsonism.
    Zijlmans JC
    Neuroimaging Clin N Am; 2010 Feb; 20(1):69-76. PubMed ID: 19959019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular imaging in assessing degenerative parkinsonism - an updated review.
    Nicastro N; Garibotto V; Burkhard PR
    Swiss Med Wkly; 2018; 148():w14621. PubMed ID: 29698545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging in Parkinsonian Disorders.
    Tripathi M; Kumar A; Bal C
    Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field.
    Verger A; Grimaldi S; Ribeiro MJ; Frismand S; Guedj E
    Ann Neurol; 2021 Nov; 90(5):711-719. PubMed ID: 34338333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
    Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional neuroimaging with SPECT in Parkinson's disease and Parkinsonisms].
    Lorenzo-Bosquet C; Hernández-Vara J; Castell-Conesa J; Miquel-Rodríguez F
    Rev Neurol; 2008 Apr 1-15; 46(7):430-5. PubMed ID: 18389463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.
    Jennings DL; Seibyl JP; Oakes D; Eberly S; Murphy J; Marek K
    Arch Neurol; 2004 Aug; 61(8):1224-9. PubMed ID: 15313838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of positron emission tomography imaging in movement disorders.
    Bohnen NI; Frey KA
    Neuroimaging Clin N Am; 2003 Nov; 13(4):791-803. PubMed ID: 15024962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.
    Catafau AM; Tolosa E;
    Mov Disord; 2004 Oct; 19(10):1175-82. PubMed ID: 15390019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.
    Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE
    BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of molecular imaging in the differential diagnosis of parkinsonism.
    Booij J; Teune LK; Verberne HJ
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):17-26. PubMed ID: 22460157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.